| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |